Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - TOTAL CURRENT ASSETS
Total Current Assets ESPR - Esperion Therapeutics, Inc.
201 M
LAST VALUE
-21.82%
2 YEAR CAGR
7.11%
5 YEAR CAGR
12.74%
10 YEAR CAGR